Literature DB >> 3907677

Comparison of oxyfedrine and atenolol in angina pectoris--a double-blind study.

L Fananapazir, C Bray.   

Abstract

We have compared oxyfedrine 24 mg four times daily with atenolol 100 mg once daily in the relief of angina pectoris in a double-blind cross-over study; assessments were by diary cards and treadmill testing. Both oxyfedrine and atenolol reduced the frequency of angina by similar amounts and both produced similar improvements in treadmill performance. Side effects were infrequent and minor with both drugs. The model of action of oxyfedrine appears to be different from atenolol. Oxyfedrine allows the double product of systolic blood pressure X heart rate at peak exercise to be maintained at levels similar to those with placebo; the double product at peak exercise is significantly less with atenolol.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3907677      PMCID: PMC1400900          DOI: 10.1111/j.1365-2125.1985.tb05085.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  Comparison of beta-adrenoceptor blockers under maximal exercise (pindolol v metoprolol v atenolol).

Authors:  J Erikssen; E Thaulow; R Mundal; P Opstad; S Nitter-Hauge
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

2.  The value of exercise stress testing in predicting benefit from aorto coronary bypass surgery.

Authors:  R J Stuart; D A Ziprick; M H Ellestad
Journal:  Angiology       Date:  1979-06       Impact factor: 3.619

3.  Possible mechanisms of action of oxyfedrine as an antianginal drug.

Authors:  J R Parratt; J E Mackenzie
Journal:  Br J Clin Pharmacol       Date:  1981-03       Impact factor: 4.335

4.  Regional myocardial blood flow and segmental wall function after oxyfedrine administration in the ischaemic porcine heart.

Authors:  H C Schamhardt; P D Verdouw; T M van der Hoek; P R Saxena
Journal:  Cardiovasc Res       Date:  1980-08       Impact factor: 10.787

5.  The haemodynamic effects of prolonged oral administration of oxyfedrine, a partial agonist at beta-adrenoceptors: comparison with propranolol.

Authors:  J R Parratt
Journal:  Br J Pharmacol       Date:  1974-05       Impact factor: 8.739

6.  Oxyfedrine and propranolol. A comparative experimental approach to protect myocardium against isoprenaline-induced myocardial necrosis.

Authors:  S D Seth; M P Gupta; M Gupta; S C Manchanda
Journal:  Arzneimittelforschung       Date:  1984

7.  A controlled comparison of oxyfedrine, isosorbide dinitrate and placebo in the treatment of patients suffering attacks of angina pectoris.

Authors:  J Whittington; E B Raftery
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

8.  Oxyfederine and propranolol--a controlled trial in angina pectoris.

Authors:  J Whittington; E B Raftery
Journal:  Br J Clin Pharmacol       Date:  1980-11       Impact factor: 4.335

9.  A comparison of once and twice daily atenolol for angina pectoris.

Authors:  R M Boyle; C L Bray; N Naqvi; R S Croxson; J M Cruickshank
Journal:  Int J Cardiol       Date:  1983-04       Impact factor: 4.164

  9 in total
  3 in total

Review 1.  Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.

Authors:  A N Wadworth; D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

2.  Effects of oxyfedrine on regional myocardial blood flow in patients with coronary artery disease.

Authors:  J C Kaski; L Araujo; A Maseri
Journal:  Cardiovasc Drugs Ther       Date:  1991-12       Impact factor: 3.727

Review 3.  Clinical pharmacokinetics of vasodilators. Part II.

Authors:  R Kirsten; K Nelson; D Kirsten; B Heintz
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.